Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Drug Eluting Balloons Market

ID: MRFR/HC/20571-HCR
128 Pages
Satyendra Maurya
Last Updated: April 15, 2026

Drug Eluting Balloons Market Research Report Information By Product (Coronary Drug Eluting Balloon, Peripheral Drug Eluting Balloon And Others), By Technology (Paccocath, FreePac, TransPax, EnduraCoat, Others), By End-user (Hospitals and Ambulatory Surgery Centers, Cath Labs And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Drug Eluting Balloons Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Product (USD Billion) | |
      1. 4.1.1 Coronary Drug Eluting Balloon | |
      2. 4.1.2 Peripheral Drug Eluting Balloon | |
      3. 4.1.3 Others |
    2. 4.2 Healthcare, BY Technology (USD Billion) | |
      1. 4.2.1 Paccocath | |
      2. 4.2.2 FreePac | |
      3. 4.2.3 TransPax | |
      4. 4.2.4 EnduraCoat | |
      5. 4.2.5 Others |
    3. 4.3 Healthcare, BY End-user (USD Billion) | |
      1. 4.3.1 Hospitals and Ambulatory Surgery Centers | |
      2. 4.3.2 Cath Labs | |
      3. 4.3.3 Others |
    4. 4.4 Healthcare, BY Region (USD Billion) | |
      1. 4.4.1 North America | | |
        1. 4.4.1.1 US | | |
        2. 4.4.1.2 Canada | |
      2. 4.4.2 Europe | | |
        1. 4.4.2.1 Germany | | |
        2. 4.4.2.2 UK | | |
        3. 4.4.2.3 France | | |
        4. 4.4.2.4 Russia | | |
        5. 4.4.2.5 Italy | | |
        6. 4.4.2.6 Spain | | |
        7. 4.4.2.7 Rest of Europe | |
      3. 4.4.3 APAC | | |
        1. 4.4.3.1 China | | |
        2. 4.4.3.2 India | | |
        3. 4.4.3.3 Japan | | |
        4. 4.4.3.4 South Korea | | |
        5. 4.4.3.5 Malaysia | | |
        6. 4.4.3.6 Thailand | | |
        7. 4.4.3.7 Indonesia | | |
        8. 4.4.3.8 Rest of APAC | |
      4. 4.4.4 South America | | |
        1. 4.4.4.1 Brazil | | |
        2. 4.4.4.2 Mexico | | |
        3. 4.4.4.3 Argentina | | |
        4. 4.4.4.4 Rest of South America | |
      5. 4.4.5 MEA | | |
        1. 4.4.5.1 GCC Countries | | |
        2. 4.4.5.2 South Africa | | |
        3. 4.4.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Medtronic (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Boston Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 B. Braun Melsungen AG (DE) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Abbott Laboratories (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Cordis Corporation (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Cook Medical (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Terumo Corporation (JP) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Asahi Intecc Co., Ltd. (JP) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Essen Medical (DE) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY PRODUCT |
    7. 6.4 US MARKET ANALYSIS BY TECHNOLOGY |
    8. 6.5 US MARKET ANALYSIS BY END-USER |
    9. 6.6 CANADA MARKET ANALYSIS BY PRODUCT |
    10. 6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY |
    11. 6.8 CANADA MARKET ANALYSIS BY END-USER |
    12. 6.9 EUROPE MARKET ANALYSIS |
    13. 6.10 GERMANY MARKET ANALYSIS BY PRODUCT |
    14. 6.11 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
    15. 6.12 GERMANY MARKET ANALYSIS BY END-USER |
    16. 6.13 UK MARKET ANALYSIS BY PRODUCT |
    17. 6.14 UK MARKET ANALYSIS BY TECHNOLOGY |
    18. 6.15 UK MARKET ANALYSIS BY END-USER |
    19. 6.16 FRANCE MARKET ANALYSIS BY PRODUCT |
    20. 6.17 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
    21. 6.18 FRANCE MARKET ANALYSIS BY END-USER |
    22. 6.19 RUSSIA MARKET ANALYSIS BY PRODUCT |
    23. 6.20 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
    24. 6.21 RUSSIA MARKET ANALYSIS BY END-USER |
    25. 6.22 ITALY MARKET ANALYSIS BY PRODUCT |
    26. 6.23 ITALY MARKET ANALYSIS BY TECHNOLOGY |
    27. 6.24 ITALY MARKET ANALYSIS BY END-USER |
    28. 6.25 SPAIN MARKET ANALYSIS BY PRODUCT |
    29. 6.26 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
    30. 6.27 SPAIN MARKET ANALYSIS BY END-USER |
    31. 6.28 REST OF EUROPE MARKET ANALYSIS BY PRODUCT |
    32. 6.29 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
    33. 6.30 REST OF EUROPE MARKET ANALYSIS BY END-USER |
    34. 6.31 APAC MARKET ANALYSIS |
    35. 6.32 CHINA MARKET ANALYSIS BY PRODUCT |
    36. 6.33 CHINA MARKET ANALYSIS BY TECHNOLOGY |
    37. 6.34 CHINA MARKET ANALYSIS BY END-USER |
    38. 6.35 INDIA MARKET ANALYSIS BY PRODUCT |
    39. 6.36 INDIA MARKET ANALYSIS BY TECHNOLOGY |
    40. 6.37 INDIA MARKET ANALYSIS BY END-USER |
    41. 6.38 JAPAN MARKET ANALYSIS BY PRODUCT |
    42. 6.39 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
    43. 6.40 JAPAN MARKET ANALYSIS BY END-USER |
    44. 6.41 SOUTH KOREA MARKET ANALYSIS BY PRODUCT |
    45. 6.42 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
    46. 6.43 SOUTH KOREA MARKET ANALYSIS BY END-USER |
    47. 6.44 MALAYSIA MARKET ANALYSIS BY PRODUCT |
    48. 6.45 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
    49. 6.46 MALAYSIA MARKET ANALYSIS BY END-USER |
    50. 6.47 THAILAND MARKET ANALYSIS BY PRODUCT |
    51. 6.48 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
    52. 6.49 THAILAND MARKET ANALYSIS BY END-USER |
    53. 6.50 INDONESIA MARKET ANALYSIS BY PRODUCT |
    54. 6.51 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
    55. 6.52 INDONESIA MARKET ANALYSIS BY END-USER |
    56. 6.53 REST OF APAC MARKET ANALYSIS BY PRODUCT |
    57. 6.54 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
    58. 6.55 REST OF APAC MARKET ANALYSIS BY END-USER |
    59. 6.56 SOUTH AMERICA MARKET ANALYSIS |
    60. 6.57 BRAZIL MARKET ANALYSIS BY PRODUCT |
    61. 6.58 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
    62. 6.59 BRAZIL MARKET ANALYSIS BY END-USER |
    63. 6.60 MEXICO MARKET ANALYSIS BY PRODUCT |
    64. 6.61 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
    65. 6.62 MEXICO MARKET ANALYSIS BY END-USER |
    66. 6.63 ARGENTINA MARKET ANALYSIS BY PRODUCT |
    67. 6.64 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
    68. 6.65 ARGENTINA MARKET ANALYSIS BY END-USER |
    69. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT |
    70. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
    71. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER |
    72. 6.69 MEA MARKET ANALYSIS |
    73. 6.70 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT |
    74. 6.71 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
    75. 6.72 GCC COUNTRIES MARKET ANALYSIS BY END-USER |
    76. 6.73 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT |
    77. 6.74 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
    78. 6.75 SOUTH AFRICA MARKET ANALYSIS BY END-USER |
    79. 6.76 REST OF MEA MARKET ANALYSIS BY PRODUCT |
    80. 6.77 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
    81. 6.78 REST OF MEA MARKET ANALYSIS BY END-USER |
    82. 6.79 KEY BUYING CRITERIA OF HEALTHCARE |
    83. 6.80 RESEARCH PROCESS OF MRFR |
    84. 6.81 DRO ANALYSIS OF HEALTHCARE |
    85. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    86. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    87. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE |
    88. 6.85 HEALTHCARE, BY PRODUCT, 2024 (% SHARE) |
    89. 6.86 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Billion) |
    90. 6.87 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
    91. 6.88 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
    92. 6.89 HEALTHCARE, BY END-USER, 2024 (% SHARE) |
    93. 6.90 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion) |
    94. 6.91 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    95. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    96. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY END-USER, 2025-2035 (USD Billion) |
    97. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY END-USER, 2025-2035 (USD Billion) |
    98. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY END-USER, 2025-2035 (USD Billion) |
    99. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY END-USER, 2025-2035 (USD Billion) |
    100. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY END-USER, 2025-2035 (USD Billion) |
    101. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY END-USER, 2025-2035 (USD Billion) |
    102. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY END-USER, 2025-2035 (USD Billion) |
    103. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY END-USER, 2025-2035 (USD Billion) |
    104. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY END-USER, 2025-2035 (USD Billion) |
    105. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY END-USER, 2025-2035 (USD Billion) |
    106. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY END-USER, 2025-2035 (USD Billion) |
    107. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY END-USER, 2025-2035 (USD Billion) |
    108. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY END-USER, 2025-2035 (USD Billion) |
    109. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY END-USER, 2025-2035 (USD Billion) |
    110. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY END-USER, 2025-2035 (USD Billion) |
    111. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY END-USER, 2025-2035 (USD Billion) |
    112. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY END-USER, 2025-2035 (USD Billion) |
    113. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY END-USER, 2025-2035 (USD Billion) |
    114. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY END-USER, 2025-2035 (USD Billion) |
    115. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY END-USER, 2025-2035 (USD Billion) |
    116. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY END-USER, 2025-2035 (USD Billion) |
    117. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY END-USER, 2025-2035 (USD Billion) |
    118. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY END-USER, 2025-2035 (USD Billion) |
    119. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY END-USER, 2025-2035 (USD Billion) |
    120. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY END-USER, 2025-2035 (USD Billion) |
    121. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY END-USER, 2025-2035 (USD Billion) |
    122. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY END-USER, 2025-2035 (USD Billion) |
    123. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY END-USER, 2025-2035 (USD Billion) |
    124. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY PRODUCT, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY END-USER, 2025-2035 (USD Billion) |
    125. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    126. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Product (USD Billion, 2025-2035)

  • Coronary Drug Eluting Balloon
  • Peripheral Drug Eluting Balloon
  • Others

Healthcare By Technology (USD Billion, 2025-2035)

  • Paccocath
  • FreePac
  • TransPax
  • EnduraCoat
  • Others

Healthcare By End-user (USD Billion, 2025-2035)

  • Hospitals and Ambulatory Surgery Centers
  • Cath Labs
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions